SMARCA4/BRG1 Is a Novel Prognostic Biomarker Predictive of Cisplatin-Based Chemotherapy Outcomes in Resected Non-Small Cell Lung Cancer
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-15-1468
Full Text
Open PDFAbstract
Available in full text
Date
December 15, 2015
Authors
Publisher
American Association for Cancer Research (AACR)